RAGE: a novel cellular receptor for advanced glycation end products. - Wikidata - wikimedia - TriplyDB

RAGE: a novel cellular receptor for advanced glycation end products.

RAGE: a novel cellular receptor for advanced glycation end products.

http://www.wikidata.org/entity/Q41011414

about

Dietary advanced glycation end products and their role in health and disease Advanced Glycation End Product Recognition by the Receptor for AGEs Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding Periodontitis and risk of diabetes mellitus.Early glycation products produce pentosidine cross-links on native proteins. novel mechanism of pentosidine formation and propagation of glycation.Altered retinoic acid metabolism in diabetic mouse kidney identified by O isotopic labeling and 2D mass spectrometry.Plasma levels of the pro-inflammatory protein S100A12 (EN-RAGE) are associated with muscle and fat mass in hemodialysis patients: a cross-sectional study.The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice Genetic modifiers of atherosclerosis in mice RAGE expression in human T cells: a link between environmental factors and adaptive immune responses.Reaction of carnosine with aged proteins: another protective process?Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children Diabetes and periodontitis.Advanced glycation endproducts and osteoarthritis.Receptor for advanced glycation end products (RAGE) prevents endothelial cell membrane resealing and regulates F-actin remodeling in a beta-catenin-dependent manner Prenatal dietary load of Maillard reaction products combined with postnatal Coca-Cola drinking affects metabolic status of female Wistar rats.Activation and resolution of periodontal inflammation and its systemic impact.The influence of type 2 diabetes mellitus on salivary matrix metalloproteinase-8 levels and periodontal parameters: A study in an Indian population.Characteristics of inflammation common to both diabetes and periodontitis: are predictive diagnosis and targeted preventive measures possible?From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain.Genetic analysis of advanced glycation end products in the DHS MIND study.Treating chronic periodontitis: current status, challenges, and future directions.sRAGE induces human monocyte survival and differentiation Fundamental role of C1q in autoimmunity and inflammation N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.Cellular signaling and potential new treatment targets in diabetic retinopathy.Molecular mechanisms involved in the bidirectional relationship between diabetes mellitus and periodontal disease.Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.Role of the advanced glycation end products receptor in Crohn's disease inflammation.Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease.New thoughts on the initiation of mucositis.HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation.Oxidative stress and β-amyloid protein in Alzheimer's disease.Pathophysiology of the diabetic kidney.The emerging role of the receptor for advanced glycation end products on innate immunity.

P2860

Q26801247-3A9951AD-D19F-41FF-8BCD-91B3FBDA67BF Q27667822-AA6750D9-A43C-439A-9A36-3790987EBD9E Q28362386-79CA869F-FE67-4019-BB16-A7E37B050C62 Q28570142-8C0B5432-5AE6-4225-ADFC-F9DBC9E24EF1 Q28741936-AFE8852E-056D-4357-A5E1-12C25729B6AB Q30394549-248FF369-18F6-441E-B0E5-8819091993A5 Q31561110-6355198F-021D-4B16-9291-4AEB16508BEA Q33608656-E1AA7614-5ECA-40CD-85DF-38A90DDDB013 Q33723012-689F9086-C617-45D0-AD6E-240AF7D82112 Q33853348-E1012B26-F46A-4523-A2A8-AEC79E2D8DE5 Q33918403-D0687445-B52A-4A9E-84BD-699BA6DEFFBD Q34080318-BE7B81D7-26C1-488E-A65B-D8F13295C2F6 Q34235391-D6524CC1-A356-4E7A-9EB7-9664D764C974 Q34614510-A872C0E8-5997-460F-8B33-1E99693034A8 Q34760887-269CEF94-BC82-4D14-8E27-5421D14ECEC8 Q34987953-8320CEBD-6672-4FCB-A82B-0678D6EB509F Q35039955-336CF910-C9E7-49EE-88E1-99A794D91C29 Q35053820-89BFA6C3-D764-499D-A8D1-090C95BE0039 Q35067948-CC09F35C-61F0-4F58-805A-CFE2463EE7D2 Q35266372-18B06984-77EA-4E62-A9B9-F6A533266784 Q35539571-667D5E40-E3F4-49B9-B96F-81DFA509C9D0 Q35932966-898615E4-27B2-4874-96AE-6D879248BE04 Q36059983-DD0D2261-5FCD-413D-B11F-786DAF064824 Q36117590-81418BE8-D7E2-4C23-8BE8-6C7818CA214E Q36629895-5FE6AF1B-8672-4B5A-8C2D-899010D413CB Q36785519-C1F1CC67-DE75-4F26-95D5-B77D6799366A Q36819785-50140899-226E-440A-9F2E-97979C454E31 Q36900801-57597FA0-9BF9-4928-9288-8CB8C1FC3A85 Q36972852-F69699D9-0E97-437C-9B70-920ADC06DA84 Q37036184-1DFBBB7A-2D01-4DBC-B21E-F56B42069EEE Q37089750-48BB4FC9-D821-480A-BF10-7215DB4D10D7 Q37158663-DCD22700-7007-4D23-ABF1-BE9E043F8C72 Q37226580-2F77582F-CE1E-4D9A-8F15-28F329B4009F Q37378925-01F7B90F-1005-4ED6-AB3B-EF6CB2AE66C1 Q37541359-D0D7F735-7DAC-4FC0-979A-C87A51748B27 Q37789403-1C3F279B-B3A2-4EE3-A821-9E082BDBAB69 Q37876420-7065D8E5-B5AA-4747-88CB-9AC17D6139EF Q37928994-5BF37673-0BEF-4394-B009-24398CF90A91 Q38111707-EA7E9E0F-CE0C-4064-8D79-FED7831BDEDF Q38165257-B1421893-E504-4D65-BB91-3994D2B85FCF

P2860

RAGE: a novel cellular receptor for advanced glycation end products.

http://www.wikidata.org/entity/Q41011414

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

RAGE: a novel cellular receptor for advanced glycation end products.

@en

type

label

RAGE: a novel cellular receptor for advanced glycation end products.

@en

prefLabel

RAGE: a novel cellular receptor for advanced glycation end products.

@en

P1433

Q41011414-F9743D5D-1F90-4B1A-BFA1-5BE41749E342

P1476

Q41011414-F7116797-D2FA-4CBA-A9A0-FB0825CA8F48

P2093

Q41011414-0DBA723F-914A-4FC7-81CF-226E7286060F

Q41011414-12D0FDA1-708C-4B51-9445-2D794E0B4D10

Q41011414-19C0BF60-3706-4C21-8631-92B0A3CB9FD4

Q41011414-368ACD90-5F4A-4E89-82A6-0EAC08B6B352

Q41011414-4EEB5AC9-BD3F-4D94-9649-6A5F339D3926

Q41011414-5483F13D-7458-42B2-9F71-1B52142FEB46

Q41011414-6FE11AC2-CDCC-4A56-A68E-C08DA14E7FD3

Q41011414-AA80A6B8-7531-4AF0-ACEA-5DFC553EC65D

Q41011414-C19B9854-DEDC-4570-9FEB-8761D0E30063

Q41011414-C42E28C6-0859-4248-8E0E-FF071BEEA423

P304

Q41011414-09F277F0-C514-4CB2-9DD1-F7AE2DF00B0D

P31

Q41011414-08DFA6C6-728D-4A79-85CF-6E06BC91FCA8

P356

Q41011414-FEA4C626-FFE7-4647-A6E1-3566D7FBE3BD

P407

Q41011414-1F20371F-4894-40E7-97D9-A3421BA1DB13

P478

Q41011414-F252430E-5EB7-4D8D-A0AB-011F99BF94C6

P577

Q41011414-6308A7FB-093B-4908-97F8-B508B6D84159

P698

Q41011414-817B7A37-56C3-4550-9FB5-1725B2402F89

P356

P1433

P1476

RAGE: a novel cellular receptor for advanced glycation end products.

@en

P2093

Brett J

http://www.w3.org/2001/XMLSchema#string

Cao R

http://www.w3.org/2001/XMLSchema#string

Hori O

http://www.w3.org/2001/XMLSchema#string

Kuwabara K

http://www.w3.org/2001/XMLSchema#string

Matsumoto M

http://www.w3.org/2001/XMLSchema#string

Ogawa S

http://www.w3.org/2001/XMLSchema#string

Schmidt AM

http://www.w3.org/2001/XMLSchema#string

Stern D

http://www.w3.org/2001/XMLSchema#string

Wautier JL

http://www.w3.org/2001/XMLSchema#string

Yan SD

http://www.w3.org/2001/XMLSchema#string

P304

S77-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIAB.45.3.S77

http://www.w3.org/2001/XMLSchema#string

P407

P478

45 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

1996-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8674899

http://www.w3.org/2001/XMLSchema#string